MORFMorphic Holding, Inc.

Nasdaq morphictx.com


$ 56.99 $ 0.02 (0.04 %)    

Thursday, 15-Aug-2024 15:58:42 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 56.99
$ 56.98 x 5,791
-- x --
-- - --
$ 19.35 - $ 57.00
1,795,850
na
2.85B
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-25-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 04-25-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-reiterates-sector-perform-on-morphic-holding-maintains-57-price-target

RBC Capital analyst Gregory Renza reiterates Morphic Holding (NASDAQ:MORF) with a Sector Perform and maintains $57 price tar...

 stifel-maintains-hold-on-morphic-holding-raises-price-target-to-57

Stifel analyst Alex Thompson maintains Morphic Holding (NASDAQ:MORF) with a Hold and raises the price target from $30 to $57.

 russell-2000-index-notches-strongest-week-of-year-hits-31-month-highs-outlook-is-clouded-by-feds-concerns-over-labor-market-analyst-warns

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-...

 eli-lillys-32b-morphic-deal-is-crucial-has-strategic-merit-despite-investor-attention-on-obesity-analyst

Eli Lilly's acquisition of Morphic highlights strategic expansion in Immunology, targeting α4β7 for ulcerative colitis and ...

 bmo-capital-downgrades-morphic-holding-to-market-perform-raises-price-target-to-57

BMO Capital analyst Evan David Seigerman downgrades Morphic Holding (NASDAQ:MORF) from Outperform to Market Perform and rais...

 td-cowen-downgrades-morphic-holding-to-hold

TD Cowen analyst Ritu Baral downgrades Morphic Holding (NASDAQ:MORF) from Buy to Hold.

 rbc-capital-downgrades-morphic-holding-to-sector-perform-lowers-price-target-to-57

RBC Capital analyst Gregory Renza downgrades Morphic Holding (NASDAQ:MORF) from Outperform to Sector Perform and lowers the ...

 sp-500-closes-at-record-high-ahead-of-inflation-data-fear--greed-index-remains-in-neutral-zone

The CNN Money Fear and Greed index slightly decreased, remaining in Neutral zone. US stocks mixed, with S&P 500 at record h...

 stocks-hold-steady-small-caps-rise-french-equities-slip-after-surprise-win-by-left-wing-bloc-whats-driving-markets-monday

U.S. stocks started the week on a neutral note, with the S&P 500 and Nasdaq 100 indices hovering around the flatline by mid...

 eli-lillys-first-biotech-deal-of-2024-buys-chronic-disease-player-morphic-for-32b

Eli Lilly to acquire Morphic Holding Inc for $3.2 billion, strengthening its portfolio in chronic disease treatments. Morphic&#...

 morphic-therapeutic-announced-the-presentation-of-new-data-demonstrating-novel-real-time-visualization-of-small-molecule-47-inhibition-of-gut-trafficking-cells

-α4β7 Inhibition Rapidly Increases the Rolling Velocity and Flux of B Cells in Gut-associated Lymphoid Tissues- -Impact of Pote...

 morphic-holding-q1-2024-gaap-eps-091-beats-094-estimate

Morphic Holding (NASDAQ:MORF) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(0.9...

 canaccord-genuity-maintains-buy-on-morphic-holding-lowers-price-target-to-66

Canaccord Genuity analyst Edward Nash maintains Morphic Holding (NASDAQ:MORF) with a Buy and lowers the price target from $6...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION